期刊文献+

二甲双胍抑制高糖状态下大鼠肾小球系膜细胞增殖作用机制的进一步研究

Further research of the mechanism of metformin inhibiting rat mesangial cells proliferation induced by high glucose
下载PDF
导出
摘要 目的探讨二甲双胍抑制高糖状态下大鼠肾小球系膜细胞增殖的作用机制。方法体外培养大鼠肾小球系膜细胞(HBZY-1)分为2组,AICAR组分为正常对照(NC)组(葡萄糖浓度5.6 mmol/L)、高糖(HG)组(葡萄糖浓度30 mmol/L)、HG+AICAR组(葡萄糖浓度30 mmol/L+AICAR浓度2.0 mmol/L)、HG+AICAR+二甲双胍组(葡萄糖浓度30 mmol/L+AICAR浓度2.0 mmol/L+二甲双胍浓度200 mmol/L)4个亚组,Compound C组分为NC组、HG组、HG+Compound C组(葡萄糖浓度30 mmol/L+Compound C浓度0.5 mmol/L)、HG+Compound C+二甲双胍组(葡萄糖浓度30 mmol/L+Compound C浓度0.5 mmol/L+二甲双胍浓度200 mmol/L)4个亚组,作用时间均为24 h,MTT法检测各组HBZY-1细胞增殖的情况;如上分组,作用12 h,用Western blot法检测各组细胞内p-单磷酸腺苷激活的蛋白激酶(p-AMPK)和AMPK蛋白表达的变化。结果①与NC组相比,高糖刺激24 h后HBZY-1增殖明显(P均<0.01);与HG组相比,加AICAR干预后HBZY-1增殖明显抑制,加Compound C干预后系膜细胞进一步增殖,均有显著性差异(P均<0.01);与HG+AICAR组相比,加二甲双胍干预后HBZY-1增殖进一步抑制,有显著性差异(P<0.01);与HG+Compound C组相比,加二甲双胍干预后HBZY-1增殖明显抑制,有显著性差异(P<0.01);②与NC组相比,高糖刺激24 h后HBZY-1细胞内p-AMPK表达水平明显下降(P均<0.01);与HG组相比,加AICAR干预后p-AMPK表达水平明显升高,加Compound C干预后p-AMPK表达水平进一步下降,均有显著性差异(P均<0.01);与HG+AICAR组相比,加二甲双胍干预后HBZY-1细胞内p-AMPK表达水平进一步升高,有显著性差异(P<0.01);与HG+Compound C组相比,加二甲双胍干预后p-AMPK表达水平明显升高,有显著性差异(P<0.01)。结论二甲双胍可能通过增加肾小球系膜细胞内p-AMPK的表达水平来抑制HBZY-1的增殖。 Objective It is to investigate the possible mechanism of metformin inhibiting rat mesangial cells proliferation induced by high glucose.Methods The rat mesangial cells(HBZY-1) were cultured in vitro and divided into 2 groups.AICAR group were divided into four subgroups:normal glucose (5.6 mmol/L),high glucose (30 mmol/L),high glucose plus AICAR (2.0 mmol/L),high glucose plus AICAR plus metformin (200 mmol/L) ; Compound C group were divided into four subgroups:normal glucose,high glucose,high glucose plus Compound C (0.5 mmol/L),high glucose plus Compound C plus metformin (200 mmol/L),all the application time was 24 h.The proliferations of HBZY-1 cells were detected by micro-tetrazolium salt colorimetric enzyme reaction test (MTT).The grouping was the same as the step above,all the application time was 12 h.The protein levels of p-AMPK,AMPK were measured by Western blotting.Results ①As compared to normal cells,exposure of HBZY-1 cells to D-glucose at concentration of 30 mmol/L caused significant proliferations at 24 h (P < 0.01).The addition of AICAR significantly attenuated the high glucose-enhanced proliferations of HBZY-1 cells,the proliferations were further suppressed when metformin added(P < 0.01).The addition of Compound C significantly promoted the proliferations of HBZY-1 cells,the proliferations were suppressed when metformin added(P < 0.01).②As compared to normal cells,the protein levels of p-AMPK significantly decreased in high glucose group(P < 0.01).The addition of AICAR significantly promoted the levels of p-AMPK,and when metformin added,the levels increased more obviously (P < 0.01).The addition of Compound C significantly further decreased the levels of p-AMPK,the levels were significantly increased when metformin added(P < 0.01).Conclusion Metformin can significantly reverse high glucose-regulated proliferations of HBZY-1 cells,perhaps through increasing the expression of p-AMPK protein in HBZY-1 cells.
出处 《现代中西医结合杂志》 CAS 2014年第11期1147-1149,1152,共4页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 二甲双胍 肾小球系膜细胞 高糖 P-单磷酸腺苷激活的蛋白激酶 AICAR Compound C metformin rat mesangial cell high glucose hosphorylated AMP-activated protein kinase AICAR Compound C
  • 相关文献

参考文献10

  • 1李凌云,游娜,徐家蓉,缪珩,鲁一兵,叶小龙.二甲双胍对高糖状态下大鼠肾小球系膜细胞增殖的作用及机制[J].南京医科大学学报(自然科学版),2011,31(4):487-490. 被引量:2
  • 2陈保林,蒙荣森,马跃东,熊肇军,张成喜,陈广琴,刘晨,董吁钢.AMPK对心肌细胞FOXO3a转录因子活性以及泛素连接酶MAFbx表达的影响[J].中山大学学报(医学科学版),2010,31(2):190-194. 被引量:3
  • 3张成喜,潘思年,彭朝权,熊肇军,吴震,余舒杰.二甲双胍通过激活腺苷酸活化蛋白激酶抑制大鼠心脏成纤维细胞增殖及胶原合成[J].中华临床医师杂志(电子版),2010,4(8):138-140. 被引量:2
  • 4Gagnon J,Sheppard E,Anini Y,et al.Metformin directly inhibitsghrelin secretion through AMP-activated protein kinase in rat pri-mary gastric cells[J].Diabetes,Obes Metab,2013,15(3):276-279.
  • 5Son BK,Akishita M,lijima K,et al.Adiponectin antagonizes stimu-latory effect of tumor necrosis factor-a on vascular smooth muscle cell calcification:regulation of growtharrest-specific gene 6-mediated survival pathway by adenosine 5 ’-monophosphate-activated protein kinase[J].Endocrinol,2008,149(4):1646-1653.
  • 6Lempiainen J,Finckenberg P,Levijoki J,et al.AMPK activator A-ICAR ameliorates ischemia reperfusion injury in rat kidney[J].BriJ pharmacol,2012,166(6):1905-1915.
  • 7Hoogendijk AJ,Pinhancos SS,van der Poll T,et al.AMP-activa-ted protein kinase activation by 5-aminoimidazole-4-carbox-amide-I-p-D-ribofuranoside(AICAR)reduces lipoteichoicacid-induced lung inflammation[J].J Biol Chem,2013,288(10):769-772.
  • 8Corradetti MN,Inoki K,Bardeesy N,et al.Regulation of the TSCpathway by LKBl:evidence of a molecular link between tuberoussclerosis complex and Peutz-Jeghers syndrome[J].Genes Dev,2004,18(13):1533-1538.
  • 9Nam M,Lee WH1Bac EJ,et al.Compound C inhibits clonal expan-sion of preadipocyte by increasing P21 level irrespectively of AMPKinhibition[J].Arch Biochem Biophys,2008,479(1):74-81.
  • 10Shen-Qing Wu,Gerrard,David £.Compound C,a inhibitor of AMP-actived protein kinase,inhibits glycolysis in mouse longissimus dorsipostmortem[J].Meat Science,2008,78(3):323-330.

二级参考文献44

  • 1Bodine SC,Latres E,Baumhueter S,et al.Identification of ubiquitin ligases required for skeletal muscle atrophy[J].Science,2001,294(5547):1704-1708.
  • 2Li HH,Willis MS,Lockyer P,et al.Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins[J].J Clin Invest,2007,117(11):3211-3223.
  • 3Accili D,Arden KC.FoxOs at the crossroads of cellular metabolism,differentiation,and transformation[J].Cell,2004,117(4):421-426.
  • 4Sandri M,Sandri C,Gilbert A,et al.Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy[J].Cell,2004,117(3):399-412.
  • 5Léger B,Senese R,Al-Khodairy AW,et al.Atrogin-1,MuRF1,and FoXO,as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients[J].Muscle Nerve,2009,40(1):69-78.
  • 6Skurk C,Izumiya Y,Maatz H,et al.The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling[J].J Biol Chem,2005,280(21):20814-20823.
  • 7Ni YG,Berenji K,Wang N,et al.Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling[J].Circulation,2006,114(11):1159-1168.
  • 8Lee SW,Dai G,Hu Z,et al.Regulation of muscle protein degradation:coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase[J].J Am Soc Nephrol,2004,15(6):1537-1545.
  • 9Tong JF,Yan X,Zhu MJ,et al.AMP-activated protein kinase enhances the expression of musclespecific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes[J].J Cell Biochem,2009,108(2):458-468.
  • 10Mitch WE,Goldberg AL.Mechanisms of muscle wasting:The role of the ubiquitin-proteasome pathway[J].N Engl J Med,1996,335(25):1897-1905.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部